{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:32Z","timestamp":1790975132548,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.028","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T23:25:04Z","timestamp":1584660304000},"page":"3518-3523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan"],"prefix":"10.1016","volume":"38","author":[{"given":"Farah Naz","family":"Qamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Tahir","family":"Yousafzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Junejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inayat","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeeb","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafqat","family":"Bhurgry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Afroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.028_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001998","article-title":"Typhoid fever and its association with environmental factors in the Dhaka metropolitan area of Bangladesh: a spatial and time-series approach","volume":"7","author":"Dewan","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.03.028_b0010","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1093\/cid\/ciz525","article-title":"A systematic review of typhoid fever occurrence in Africa","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2020.03.028_b0015","doi-asserted-by":"crossref","unstructured":"GBD 2017 Typhoid and Paratyphoid Collaborators. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19:369-81.","DOI":"10.1016\/S1473-3099(18)30685-6"},{"key":"10.1016\/j.vaccine.2020.03.028_b0020","unstructured":"World Health Organization. ANTIMICROBIAL RESISTANCE Global Report on Surveillance 2014."},{"key":"10.1016\/j.vaccine.2020.03.028_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1443-1","article-title":"Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis","volume":"18","author":"Browne","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.vaccine.2020.03.028_b0030","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1093\/infdis\/jiy205","article-title":"A retrospective study of laboratory-based enteric fever surveillance, Pakistan, 2012\u20132014","volume":"218","author":"Qamar","year":"2018","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2020.03.028_b0035","doi-asserted-by":"crossref","unstructured":"Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins. mBio. 2018;9.","DOI":"10.1128\/mBio.00105-18"},{"key":"10.1016\/j.vaccine.2020.03.028_b0040","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/ciy877","article-title":"Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: high time for the introduction of typhoid conjugate vaccine","volume":"68","author":"Yousafzai","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2020.03.028_b0045","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S1473-3099(18)30483-3","article-title":"Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study","volume":"18","author":"Qamar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.028_b0050","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMp1803926","article-title":"Extensively drug-resistant typhoid - are conjugate vaccines arriving just in time?","volume":"379","author":"Andrews","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2020.03.028_b0055","unstructured":"World Health Organization. Typbar TCV\u00ae from Bharat Biotech, World\u2019s First Typhoid Conjugate Vaccine Prequalified by WHO World Health Organization; 3rd January 2018."},{"key":"10.1016\/j.vaccine.2020.03.028_b0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 \u2013 Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.028_b0065","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2020.03.028_b0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.028_b0075","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.028_b0080","unstructured":"Pakistan Bureau of Statistics. 6th Population and housing census - 2017. Pakistan2017."},{"key":"10.1016\/j.vaccine.2020.03.028_b0085","article-title":"The Brighton Collaboration: creating a global standard for case definitions (and guidelines) for adverse events following immunization. Advances in patient safety: from research to implementation (volume 2: concepts and methodology): Agency for","author":"Kohl","year":"2005","journal-title":"Healthcare Res Quality (US)"},{"key":"10.1016\/j.vaccine.2020.03.028_b0090","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2015.04.060","article-title":"Surveillance of adverse events following immunization in China: Past, present, and future","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.028_b0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph) in Indian children: School based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.03.028_b0100","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children","volume":"36","author":"Capeding","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.028_b0105","article-title":"Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: a preliminary report","author":"Capeding","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.028_b0110","series-title":"Paksitan demographic and health survey 2017\u201318","author":"National Institute of Population Studies","year":"2019"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:11Z","timestamp":1759401731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":22,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303832"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}